compound or a pharmaceutically acceptable salt thereof, methods of limiting cell proliferation in a human or animal, treating a human or animal suffering from cancer, treating cancer prophylaxis, treating a human or animal suffering from a disease treatment of a human or animal suffering from a proliferative cancer treatment disease, for the treatment of cancer-associated infections, for the prophylactic treatment of cancer-associated infections, pharmaceutical composition, use of a compound or a pharmaceutically acceptable salt thereof, method of inhibiting chk1 kinase, and process for preparing a compound or a pharmaceutically acceptable salt thereof

摘要

COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT OF THE SAME, METHODS OF LIMITING CELL PROLIFERATION IN A HUMAN OR ANIMAL, TREATMENT OF A HUMAN OR ANIMAL SUFFERING FROM CANCER, PROPHYLAX TREATMENT OF A HUMAN OR SUGAR PROFILAXY NEOPLASTIC, TREATMENT OF A HUMAN OR ANIMAL SUFFERING FROM A PROLIFERATIVE CANCER TREATMENT DISEASE FOR THE TREATMENT OF CANCER-ASSOCIATED INFECTIONS FOR THE PROPHYLATIC TREATMENT OF A FEMATIC AND HEALTH-ASSOCIATED HEALTHCARE METHOD OF INHIBITING CHK1 KINASE AND THE PROCESS FOR PREPARING A PHARMACEUTICALLY ACCEPTABLE COMPOUND OR SALT OF THIS INVENTION This invention relates to novel compounds having the structural formula (I) and their pharmaceutical compositions and methods of use. These new compounds provide cancer treatment or prophylaxis.